Order Article Reprints

Akar ZA, Yıldırım D, Çiftçi M, Işık Sula Z, Karaman S, Çevik R, Karakoç M, Em S, Batmaz İ, Oktayoğlu P, et al. Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis. Diagnostics. 2026; 16(6):957. https://doi.org/10.3390/diagnostics16060957

Akar, Zeynel Abidin, Dilan Yıldırım, Mehmet Çiftçi, Zeynep Işık Sula, Serap Karaman, Remzi Çevik, Mehmet Karakoç, Serda Em, İbrahim Batmaz, Pelin Oktayoğlu, and et al. 2026. "Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis" Diagnostics 16, no. 6: 957. https://doi.org/10.3390/diagnostics16060957

Akar, Z. A., Yıldırım, D., Çiftçi, M., Işık Sula, Z., Karaman, S., Çevik, R., Karakoç, M., Em, S., Batmaz, İ., Oktayoğlu, P., & Çağlayan, M. (2026). Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis. Diagnostics, 16(6), 957. https://doi.org/10.3390/diagnostics16060957